The Allendale Investigational Review Board (AIRB), family-owned and operated since 1991, offers clinical protocol review services to Research Organizations and Contract Laboratories throughout the world. The AIRB was incorporated as a duly constituted board to support pharmaceutical, medical device, dietary supplement, consumer product and personal care product companies involved in clinical research. The AIRB’s role is to review proposed research, approve the initiation of said research and continue to review medical research involving human subjects in accordance with the US FDA regulations (21 CFR 50:1-48 +56,101-124).

In our 33-year history, the AIRB has undertaken comprehensive protocol reviews spanning an extensive array of studies. These encompass ethical pharmaceuticals, groundbreaking skin protectants, analgesics, surgical drapes, antimicrobials, spinal electrodes, feminine hygiene products, genetically engineered tomatoes, and state-of-the-art contraceptive devices. Our reviews consistently uphold the standards set forth by the FDA, EPA, CPSC, and international regulatory authorities.

Here at the AIRB, we pride ourselves on being a family-run company committed to maintaining a personalized approach in our interactions with our clients. We emphasize professionalism and timeliness, going to great lengths to align with our clients' schedules. Our IRB meets weekly and our clients have a dedicated point of contact to ensure all study needs are addressed as quickly as possible. Our rapid turnaround times ensure that our partners can have their studies reviewed and approved within the same week, and often times in as little as 1 business day.

The AIRB is a dedicated partner to research sponsors, CRO’s and study participants in navigating their clinical research journey.